Overview

Gender

male

Bob Rieder has been Executive Chairman of Cardiome Pharma (TSX: COM; NASDAQ:SRME) since April 2009 and was previously President and CEO of Cardiome since 1998. In that time, Cardiome has raised more than $90 million, and has moved first to the TSX, then to NASDAQ. Under his leadership, Cardiome has completed a successful M&A transaction, executed a marketing partnership with Fujisawa Healthcare, and taken the Company’s lead molecule into phase III clinical studies.

Bob has extensive experience in venture capital investing and in operational management. He was previously Vice-President at MDS Ventures Pacific, the Vancouver-based affiliate of MDS Capital, and has served as a director for nine public and private technology companies. Bob was Chief Operating Officer for DBA Telecom, and CEO for Synapse Technologies. He currently serves as a director of Micrologix, Cardiome, Venta and Inovio Biomedical.